Document is current
Any future updates will be listed below
-
Authors
Oelen, Yrina https://orcid.org/0000-0003-3417-0326
Revenberg, Sven
de Vos-Geelen, Judith
van Geel, Robin
Schoenmaekers, Janna
van den Beuken-Everdingen, Marieke
Valkenburg-van Iersel, Liselot
- License Information
-
More Information
Article History
Received: 25 March 2022
Accepted: 20 May 2022
First Online: 2 July 2022
Declarations
:
: Judith de Vos-Geelen has served as a consultant for Amgen, AstraZeneca, MSD, Pierre Fabre, and Servier, and has received institutional research funding from Servier. All outside the submitted work. The other authors have no conflicts of interest.
: This study is an observational study. This study was exempted from the Human Subjects Act by the medical-ethical evaluation board of the academic hospital Maastricht and Maastricht University.
: Written informed consent is obtained from all the participants in the study. Consent to publish is not of concern in the current manuscript.
